Mycobacterium xenopi pulmonary infection in an HIV infected patient under highly active antiretroviral treatment

Bachmeyer, C.; Blum, L.; Stelianides, S.; Benchaa, B.; Gruat, N.; Danne, O.
December 2001
Thorax;Dec2001, Vol. 56 Issue 12, p978
Academic Journal
Highly active antiretroviral therapy (HAART) is responsible for a striking reduction in AIDS related morbidity and mortality by partly restoring immune function. However, HAART can also precipitate the development of clinically apparent opportunistic infections in patients with latent infections. We report a case of an HIV infected patient who developed granulomatous nodular and cavitatory lesions of the lungs due to Mycobacterium xenopi as a manifestation of the immune restoration syndrome.


Related Articles

  • Tenofovir and Nephrotoxicity. Joshi, Amit; Kraus, Mark // Kidney;Nov/Dec2005, Vol. 14 Issue 6, p255 

    The article provides information on the development of antiretroviral drug tenofovir for the treatment of HIV/AIDS. Tenofovir is an acyclic nucleoside phosphonate in the class of nucleotide reverse transcriptase inhibitors. The drug interrupts DNA synthesis by terminating the elongation of the...

  • HIV/AIDS: Recent Advances in Antiretroviral Agents. Nikolopoulos, Georgios; Bonovas, Stefanos; Tsantes, Argirios; Sitaras, Nikolaos M. // Mini Reviews in Medicinal Chemistry;Jul2009, Vol. 9 Issue 8, p900 

    Despite the considerable progress in antiretroviral therapy, the eradication of HIV-1 remains unfeasible. Therefore, novel agents are under investigation. The aim of this review is to summarize the conventional compounds, to describe the recently approved agents, and to take a comprehensive look...

  • Denying science.  // Nature Medicine;Apr2006, Vol. 12 Issue 4, p369 

    The article comments on the movement of AIDS denialists in spreading conspiracy theories and misinformation to a susceptible public wary of antiretroviral drugs. Scientists have a very important role to play in explaining the science behind AIDS and showing that antiretroviral drugs can...

  • Antiretroviral Therapy and Sexual Behavior: A Comparative Study between Antiretroviral- Naive and -Experienced Patients at an Urban HIV/AIDS Care and Research Center in Kampala, Uganda. Bateganya, Moses; Colfax, Grant; Shafer, Leigh Anne; Kityo, Cissy; Mugyenyi, Peter; Serwadda, David; Mayanja, Harriet; Bangsberg, David // AIDS Patient Care & STDs;Nov2005, Vol. 19 Issue 11, p760 

    We examined whether use of antiretroviral (ARV) therapy is associated with increased sexual risk behavior in a cross-sectional study of patients undergoing ARV therapy (ARV experienced) compared to patients not undergoing ARV therapy (ARV-naïve) attending an urban HIV clinic in Kampala,...

  • HIV and Hyperlipidemia: Current Recommendations And Treatment. Capili, Bernadette; Anastasi, Joyce K. // MEDSURG Nursing;Feb2006, Vol. 15 Issue 1, p14 

    The article discusses the Highly Active Antiretroviral Therapies (HAART) as a big factor in fighting HIV and AIDS. Cardiovascular disease is also recognized as one of the subsequent diseases which is a result from AIDS virus. It was found out that this life threatening condition has now become...

  • HIV service delivery models towards 'Zero AIDS-related Deaths': a collaborative case study of 6 Asia and Pacific countries. Fujita, Masami; Poudel, Krishna C.; Green, Kimberly; Wi, Teodora; Abeyewickreme, Iyanthi; Ghidinelli, Massimo; Kato, Masaya; Mean Chhi Vun; Sopheap, Seng; Khin Ohnmar San; Bollen, Phavady; Rai, Krishna Kumar; Dahal, Atul; Bhandari, Durga; Boas, Peniel; Yaipupu, Jessica; Sirinirund, Petchsri; Saonuam, Pairoj; Bui Duc Duong; Do Thi Nhan // BMC Health Services Research;2015, Vol. 15 Issue 1, p1 

    Background: In the Asia-Pacific region, limited systematic assessment has been conducted on HIV service delivery models. Applying an analytical framework of the continuum of prevention and care, this study aimed to assess HIV service deliveries in six Asia and Pacific countries from the...

  • AIDS and the lung in a changing world. Mayaud, C.; Cadranel, J. // Thorax;Jun2001, Vol. 56 Issue 6, p423 

    This article focuses on a study that analyzed, HIV infected patients without access to prophylaxis for pulmonary infections and antiretroviral treatment and HIV infected patients with access to prophylaxis for pulmonary infections but not to antiretroviral treatment. At the beginning of the AIDS...

  • Uptake of HIV testing and treatment in an isolated population with access to free and universal healthcare. Gillieatt, Sue J.; Mallal, Simon A.; Gillieatt, S J; Mallal, S A // International Journal of STD & AIDS;May2000, Vol. 11 Issue 5, p303 

    This Western Australian study analysed clinical information from 344 people with AIDS, and experiential data from a sample of 36 people with AIDS to investigate 2 relevant issues: the timing of HIV testing and uptake and experiences of HIV drug treatment. We found that the proportion of people...

  • The Role of Self-Efficacy in HIV Treatment Adherence: Validation of the HIV Treatment Adherence Self-Efficacy Scale (HIV-ASES). Johnson, Mallory O.; Neilands, Torsten B.; Dilworth, Samantha E.; Morin, Stephen F.; Remien, Robert H.; Chesney, Margaret A. // Journal of Behavioral Medicine;Oct2007, Vol. 30 Issue 5, p359 

    Adherence to HIV treatment, including adherence to antiretroviral (ART) medication regimens, is paramount in the management of HIV. Self-efficacy for treatment adherence has been identified as an important correlate of medication adherence in the treatment of HIV and other medical conditions....


Read the Article


Sign out of this library

Other Topics